Empowered Funds’s Moderna MRNA Stock Holding History

Empowered Funds’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7M	Buy	33,436 +19,704	+143%	+$919K	0.01%	1192
2025 Q4	$405K	Buy	13,732 +353	+3%	+$9.59K	0.01%	789
2025 Q3	$346K	Buy	13,379 +242	+2%	+$6.75K	﹤0.01%	1551
2025 Q2	$362K	Buy	+13,137	New	+$346K	﹤0.01%	1438
2025 Q1	–	Sell	-5,781	Closed	-$240K	–	1729
2024 Q4	$240K	Buy	5,781 +582	+11%	+$27.8K	﹤0.01%	1451
2024 Q3	$347K	Buy	5,199 +322	+7%	+$29.6K	0.01%	1211
2024 Q2	$579K	Buy	4,877 +601	+14%	+$76.1K	0.01%	1010
2024 Q1	$456K	Buy	4,276 +904	+27%	+$91.1K	0.01%	1101
2023 Q4	$335K	Buy	3,372 +611	+22%	+$51.4K	0.01%	1084
2023 Q3	$285K	Buy	2,761 +504	+22%	+$56.2K	0.01%	1070
2023 Q2	$274K	Buy	2,257 +822	+57%	+$110K	0.01%	991
2023 Q1	$220K	Buy	+1,435	New	+$237K	0.01%	491
2022 Q3	–	Sell	-31,902	Closed	-$4.56M	–	360
2022 Q2	$4.56M	Buy	+31,902	New	+$4.56M	0.59%	37
2021 Q4	–	Sell	-4,306	Closed	-$1.66M	–	276
2021 Q3	$1.66M	Buy	+4,306	New	+$1.59M	0.21%	105

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return